Analytical Tool - Prostate Cancer

BioSeeker Group AB
March 25, 2014
SKU: BIOS5221725
The World Market for Flow Cytometry in IVD Applications
6/16/2014 | published by: Kalorama Information
The World Market for Flow Cytometry in IVD Applications Flow cytometers are powerful reference lab instruments that are now an important component of advanced IVD labs in developed nations. They are advanced diagnostic  |  read more...
USD 1,995
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update
7/7/2014 | published by: GlobalData
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick, sticky mucus which clogs the lungs and leads to  |  read more...
USD 5,995
Mitochondrial Drugs in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Mitochondrial Drugs in Oncology Drug Pipeline Update 2014 Focusing on mitochondria has recently become an intriguing target for cancer therapy. It is well known that mitochondrial activity in tumor cells is suppressed and exploiting the differences  |  read more...
USD 6,746
NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
NOD-like Receptor Signaling Pathway in Cancer Drug Pipeline Update 2014 Specific families of pattern recognition receptors are responsible for detecting various pathogens and generating innate immune responses. The intracellular NOD-like receptor (NLR) family contains more than  |  read more...
USD 4,496
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Nucleic Acid Therapies in Oncology Drug Pipeline Update 2014 Nucleic acid therapies in oncology includes: Gene Therapy, DNA vaccine, Other DNA technologies, RNA Interference (RNAi), Small interfering RNA (siRNA), Antisense RNA and Ribozymes. There are today 229  |  read more...
USD 6,746
Orphan Drugs in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Orphan Drugs in Oncology Drug Pipeline Update 2014 This is a worldwide report on cancer drugs which have now or in the past received orphan drug status. This product will give you unique access not only  |  read more...
USD 6,746
Malignant Mesothelioma - Pipeline Review, H2 2014
7/15/2014 | published by: Global Markets Direct
Malignant Mesothelioma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2014’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Malignant  |  read more...
USD 2,000
Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
Modulators of the Actin Cytoskeleton for the Treatment of Cancer Drug Pipeline Update 2014 There are today 183 companies plus partners developing 319 targeting actin cytoskeleton modulators drugs in 1200 developmental projects in cancer. In addition,  |  read more...
USD 6,746
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
mTOR Signaling Pathway in Oncology Drug Pipeline Update 2014 The mammalian target of rapamycin (mTOR) is an intracellular kinase that controls the production of proteins through its regulation of translational machinery. mTOR-activated proteins promote several hallmarks  |  read more...
USD 6,746
p53 Signaling Pathway in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
p53 Signaling Pathway in Cancer Drug Pipeline Update 2014 p53 activation is induced by a number of stress signals, including DNA damage, oxidative stress and activated oncogenes. The p53 protein is employed as a transcriptional activator  |  read more...
USD 4,496
 

SELECT A LICENSE

    Electronic Access
Global Site License Fulfilled by Publisher
  USD 11,625  
    Electronic Access
Single User Fulfilled by Publisher
  USD 4,650  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!